End Tobacco Loopholes Act
SB 819, the “End Tobacco Loopholes Act,” would substantially revise federal excise taxes in the Internal Revenue Code to create tax parity across tobacco products and nicotine products. The bill raises the federal tax rates on cigarettes, small cigars, large cigars, roll-your-own tobacco, pipe tobacco, and smokeless tobacco, while also creating a new federal excise tax on “taxable nicotine” used in vaping and other non-combustible nicotine products. It defines taxable nicotine broadly as extracted, concentrated, or synthesized nicotine, with exceptions for nicotine used in FDA-approved drugs and certain combination products.
The bill also adds new rules to prevent tax avoidance and to coordinate taxation across product categories. It treats manufacturers of taxable nicotine similarly to tobacco product manufacturers, expands the definition of processed tobacco, and includes special provisions for discrete single-use nicotine units such as pouches, lozenges, tablets, strips, and similar products. In addition, it establishes inflation indexing for tobacco tax amounts beginning after 2025 and creates floor-stocks taxes so inventory held on the effective date of a tax increase is also taxed, with special rules for foreign trade zones and transition relief for existing nicotine manufacturers seeking permits and bonds.
If enacted, SB 819 would amend multiple provisions of the Internal Revenue Code governing federal tobacco excise taxes, increasing rates and broadening the tax base to include nicotine products not previously taxed in the same way as traditional tobacco. It would affect cigarette manufacturers, cigar makers, smokeless tobacco producers, roll-your-own and pipe tobacco businesses, nicotine extraction and synthesis operations, importers, wholesalers, and retailers holding inventory on the effective date of tax increases. The bill would also require Treasury to issue guidance and regulations on valuation, classification, and anti-double-taxation rules, while creating new compliance obligations for taxable nicotine manufacturers and permit holders.
The bill’s framing and sponsorship suggest a strong public-health and anti-evasion rationale, with supporters aiming to close perceived tax loopholes and align tax treatment across tobacco and nicotine products. Because no committee transcript or vote record is provided, there is no recorded floor or committee sentiment in the available materials. Based on the text alone, the measure appears designed to be punitive toward tobacco and nicotine products and protective of federal revenue, which typically draws support from health advocates and opposition from affected industry stakeholders.
The main points of contention are likely to be the size of the tax increases, the creation of a new tax on nicotine used in vaping products, and the breadth of the definition of taxable nicotine. Tobacco and nicotine manufacturers may object that the bill treats very different products similarly, could raise consumer prices, and may burden harm-reduction products or FDA-regulated products indirectly. Another likely dispute is administrative complexity: the bill requires new classification rules, inflation adjustments, floor-stocks taxation, and coordination to avoid double taxation, all of which could be challenged by industry as difficult to implement and by regulators as resource-intensive.